Glandular fever and risk of MS

Is infectious mononucleosis the cause or trigger of MS? #MSBlog #MSResearch

“The month or season of birth effect in relation has recently been called into question by the Cambridge group (Fiddes et al. 2013) based on the observation that births in general are seasonal. However, this finding is not accepted by all as data that has corrected for overall births still show a strong month of birth effect (Staples et al. 2010). As you are aware EBV, and more importantly, infectious mononucleosis (IM) or symptomatic EBV infection is a relatively strong risk factor for developing MS. The study below confirms IM as a risk factor in both Norway and Italy, but did not show any seasonal effect. I suspect this seasonal effect will be overridden by cultural factors that dictate exposure to EBV or kissing. IM incidence tends to peak during the first and second semester or term at University. The latter may override any seasonal effect.”

“Whether or not it is EBV infection, or IM, that is the cause of MS or it triggers the immune system to respond in a way that sets up autoimmune responses is unknown. This is why we need studies that target EBV, by preventing it with vaccination, or treating it with antiviral agents. The latter is part of our Charcot Project and a grant application that we had rejected 3 times. We need to get back to work on this; it is time for a new grant application.”

BACKGROUND: Seasonal fluctuations in solar radiation and vitamin D levels could modulate the immune response against Epstein-Barr virus (EBV) infection and influence the subsequent risk of multiple sclerosis (MS). 

METHODS: Altogether 1660 MS patients and 3050 controls from Norway and Italy participating in the multinational case-control study of Environmental Factors In Multiple Sclerosis (EnvIMS) reported season of past infectious mononucleosis (IM).

RESULTS: IM was generally reported more frequently in Norway (p=0.002), but was associated with MS to a similar degree in Norway (odds ratio (OR) 2.12, 95% confidence interval (CI) 1.64-2.73) and Italy (OR 1.72, 95% CI 1.17-2.52). For all participants, there was a higher reported frequency of IM during spring compared to fall (p<0.0005). Stratified by season of IM, the ORs for MS were 1.58 in spring (95% CI 1.08-2.31), 2.26 in summer (95% CI 1.46-3.51), 2.86 in fall (95% CI 1.69-4.85) and 2.30 in winter (95% CI 1.45-3.66).

CONCLUSIONS: IM is associated with MS independently of season, and the association is not stronger for IM during spring, when vitamin D levels reach nadir. The distribution of IM may point towards a correlation with solar radiation or other factors with a similar latitudinal and seasonal variation.

About the author

Prof G

Professor of Neurology, Barts & The London. MS & Preventive Neurology thinker, blogger, runner, vegetable gardener, husband, father, cook and wine & food lover.


Leave a Reply to Peter Bates Cancel reply

  • Does it not beg the question that the first line of treatment for MSers should be detailed blood-work followed by antibiotics?. Cheaper and maybe more effective. I work on the theory that a dormant virus in the body is triggered by an event such as stress/accident/trauma/another virus which puts the immune system into overdrive. But what do I know1.

    • Antibiotics wouldn't be much use as they are anti-bacterial. There are anti-viral drugs but they are only effective against a small number of viruses. The INSPIRE project is using an anti-retroviral drug in RRMS. There is nothing that seems to work against EBV (thought to be a trigger for MS) for example.

By Prof G



Recent Posts

Recent Comments